ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Neuropace Inc

Neuropace Inc (NPCE)

15,74
-0,58
(-3,55%)
Geschlossen 06 Juni 10:00PM
15,69
-0,05
(-0,32%)
Nach Börsenschluss: 1:59AM

Neuropace Inc (NPCE) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
15,74
( -3,55% )
Gebot
11,99
Fragen
20,81
Volumen
134.117
15,68 Tagesbereich 16,792
7,5625 52-Wochen-Bereich 19,60
Marktkapitalisierung
Handelsende
16,32
Handelsbeginn
16,30
Letzte Trade
1
@
15.76
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.176.826
VWAP
16,2308
Durchschnittliches Volumen (3 Mio.)
US$ 210.555
Ausgegebene Aktien
34.093.745
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-25,53
Gewinn pro Aktie (EPS)
-0,65
Erlöse (LTM)
99,53M
Nettogewinn (LTM)
-21,57M

Über Neuropace Inc

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurosti... NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Hauptsitz
Mountain View, United States
Gegründet
1997
Neuropace Inc is listed in the Healthcare sector of the NASDAQ with ticker NPCE. The last closing price for Neuropace was US$16,32. Over the last year, Neuropace shares have traded in a share price range of US$ 7,5625 to US$ 19,60.

Neuropace currently has 34.093.745 shares in issue. The market capitalisation of Neuropace is US$536,64 million. Neuropace has a price to earnings ratio (PE ratio) of -25.53.

NPCE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.65-9.4882116158717.3917.649915.6418253316.30610067CS
4-3.76-19.282051282119.519.613.650120443316.31777755CS
121.5210.689170182814.2219.612.4719045315.65275413CS
26-1.07-6.3652587745416.8119.612.4720002615.643367CS
522.5719.514047076713.1719.67.562521879313.11468203CS
15611.62282.0388349514.1219.63.815172912.17620135CS
260-6.75-30.013339261922.4925.751.2211473811.65119815CS

NPCE - Frequently Asked Questions (FAQ)

What is the current Neuropace Inc share price?
The current share price of Neuropace Inc is US$ 15,74
How many Neuropace Inc shares are in issue?
Neuropace Inc has 34.093.745 shares in issue
What is the market cap of Neuropace Inc?
The market capitalisation of Neuropace Inc is USD 536,64M
What is the 1 year trading range for Neuropace Inc share price?
Neuropace Inc has traded in the range of US$ 7,5625 to US$ 19,60 during the past year
What is the PE ratio of Neuropace Inc?
The price to earnings ratio of Neuropace Inc is -25,53
What is the cash to sales ratio of Neuropace Inc?
The cash to sales ratio of Neuropace Inc is 5,67
What is the registered address of Neuropace Inc?
The registered address for Neuropace Inc is 455 North Bernardo Avenue, Mountain View, California, 94043
What is the Neuropace Inc website address?
The website address for Neuropace Inc is www.neuropace.com
Which industry sector does Neuropace Inc operate in?
Neuropace Inc operates in the Medical Equipment & Supplies sector

NPCE Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen